Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesEffects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N-carboxymethyl lysine
Journal of Diabetes and its Complications, 08/31/09
Kawai T et al. – Epalrestat suppressed the deterioration of diabetic peripheral neuropathy, especially in the lower extremity. Its effects might be mediated by improvement of the polyol pathway and suppression of production of AGEs.
Related Articles
Association of metformin, elevated homocysteine and methylmalonic acid levels, and clinically worsened diabetic peripheral neuropathy
Diabetes Care, 11/02/09
Relevance Score: 82%%
Transforming growth factor beta 1 as a biomarker of diabetic peripheral neuropathy: cross-sectional study
Journal of Diabetes and its Complications, 10/12/09
Relevance Score: 82%%
Prevalence and Risk Factors of Somatic and Autonomic Neuropathy in Prediabetic and Diabetic Patients
Neuroepidemiology, 11/11/09
Relevance Score: 81%%
Association of metformin, elevated homocysteine and methylmalonic acid levels, and clinically worsened diabetic peripheral neuropathy
Diabetes Care, 10/30/09
Relevance Score: 81%%
Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies
Annals of Oncology, 11/16/09
Relevance Score: 80%%
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines
Neuroendocrinology, 11/24/09
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Today in Neuropathy/Myopathy...keeping you current
Receive free subspecialty "5-minute updates" via email
Prevalence of Symptomatic Charcot-Marie-Tooth Disease in Iceland: A Study of a Well-Defined Population
Neuroepidemiology , 11/25/09
Multifocal Paraneoplastic Cortical Encephalitis Associated With Myasthenia Gravis and Thymoma
Archives of Neurology, 11/24/09
Differential Immunohistological Features of Inflammatory Myopathies and Dysferlinopathy
Journal of Korean Medical Science, 11/24/09
Sponsor
Article Search
Sponsor